Clinical Trial Update: A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of GSK1278863 in non-dialysis dependent CKD-associated anemia has completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 2 | Status: COMPLETED | Results posted: 2016-06-06